M J McElrath
Overview
Explore the profile of M J McElrath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
2055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hertz T, Logan M, Rolland M, Magaret C, Rademeyer C, Fiore-Gartland A, et al.
Vaccine
. 2016 Oct;
34(47):5792-5801.
PMID: 27756485
Introduction: The Merck Adenovirus-5 Gag/Pol/Nef HIV-1 subtype-B vaccine evaluated in predominately subtype B epidemic regions (Step Study), while not preventing infection, exerted vaccine-induced immune pressure on HIV-1 breakthrough infections. Here...
2.
Lemos M, Karuna S, Mize G, Fong Y, Montano S, Ganoza C, et al.
Mucosal Immunol
. 2015 Oct;
9(3):798-808.
PMID: 26509877
We profiled the humoral response in the penis, an area that has been minimally explored but may be relevant for protecting insertive men against HIV and other sexually acquired infections....
3.
Bigham A, Mackelprang R, Celum C, de Bruyn G, Beima-Sofie K, John-Stewart G, et al.
J Acquir Immune Defic Syndr
. 2014 Jan;
66(2):127-34.
PMID: 24463784
Objective: We evaluated genetic variants in 51 candidate genes encoding proteins that interact with HIV-1 during the virus life cycle for association with HIV-1 outcomes in an African cohort. Methods:...
4.
McElrath M, Smythe K, Randolph-Habecker J, Melton K, Goodpaster T, Hughes S, et al.
J Acquir Immune Defic Syndr
. 2013 Feb;
63(3):263-71.
PMID: 23392465
Background: Prevention of rectal HIV transmission is a high-priority goal for vaccines and topical microbicides because a large fraction of HIV transmissions occurs rectally. Yet, little is known about the...
5.
Celum C, Wald A, Lingappa J, Magaret A, Wang R, Mugo N, et al.
N Engl J Med
. 2010 Jan;
362(5):427-39.
PMID: 20089951
Background: Most persons who are infected with human immunodeficiency virus type 1 (HIV-1) are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated and is associated...
6.
Malhotra U, Nolin J, Horton H, Li F, Corey L, Mullins J, et al.
Vaccine
. 2009 Sep;
27(48):6678-87.
PMID: 19747576
To understand how broad recognition of HIV-1 variants may be achieved we examined T-cell reactivity in newly infected persons as well as vaccine recipients to a broad spectrum of potential...
7.
Crawford D, Zheng N, Speelmon E, Stanaway I, Rieder M, Nickerson D, et al.
Genes Immun
. 2009 Aug;
10(8):715-21.
PMID: 19657357
Signatures of natural selection occur throughout the human genome and can be detected at the sequence level. We have re-sequenced ABCE1, a host candidate gene essential for HIV-1 capsid assembly,...
8.
Zheng N, Kiviat N, Sow P, Hawes S, Wilson A, Diallo-Agne H, et al.
J Virol
. 2004 Nov;
78(24):13934-42.
PMID: 15564501
Human immunodeficiency virus type 2 (HIV-2) infection is typically less virulent than HIV-1 infection, which may permit the host to mount more effective, sustained T-cell immunity. We investigated antiviral gamma...
9.
Musey L, Ding Y, Cao J, Lee J, Galloway C, Yuen A, et al.
J Virol
. 2002 Dec;
77(1):291-300.
PMID: 12477834
Induction of adaptive immunity to human immunodeficiency virus type 1 (HIV-1) at the mucosal site of transmission is poorly understood but crucial in devising strategies to control and prevent infection....
10.
Ferrari G, Neal W, Jones A, Olender N, Ottinger J, Ha R, et al.
Immunol Lett
. 2001 Oct;
79(1-2):37-45.
PMID: 11595288
We evaluated MHC-class I-restricted CTL responses induced by HIV-1 clade B-based vaccines in nine HIV-1 seronegative vaccine recipients with regard to their patterns of HLA restriction and epitope recognition. We...